The Prognosis of Pulmonary Metastasectomy Depends on the Location of the Primary Colorectal Cancer

被引:51
|
作者
Cho, Jong Ho [1 ]
Hamaji, Masatsugu [1 ]
Allen, Mark S. [1 ]
Cassivi, Stephen D. [1 ]
Nichols, Francis C., III [1 ]
Wigle, Dennis A. [1 ]
Shen, K. Robert [1 ]
Deschamps, Claude [1 ]
机构
[1] Mayo Clin, Div Gen Thorac Surg, Rochester, MN 55905 USA
来源
ANNALS OF THORACIC SURGERY | 2014年 / 98卷 / 04期
关键词
LUNG METASTASES; PULMICC-TRIAL; COLON-CANCER; CARCINOMA; SURVIVAL; MANAGEMENT; RECURRENCE; RESECTION;
D O I
10.1016/j.athoracsur.2014.05.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Rectal cancer has a higher risk of developing lung metastasis compared with colon cancer. It is unclear whether the prognosis after pulmonary metastasectomy for these distinct tumors is different. Methods. Patients who underwent pulmonary metastasectomy for colorectal carcinoma were analyzed for survival and patterns of recurrence depending on the location of the primary colorectal cancer. Multivariate regression analysis was performed to identify clinical variables predictive of survival after pulmonary metastasectomy. Results. Between 1985 and 2012, 698 patients underwent pulmonary metastasectomy for metastatic colorectal cancer. Complete information was available in 626 patients. These patients were divided into groups based on whether the primary tumor was colon or rectal in origin. Median follow-up was 45.5 months (range, 23 to 287 months). There were no statistical differences between the two groups in terms of number of lung metastases, tumor size, or lymph node involvement. There was no difference in overall survival (p = 0.545). Five-year disease-free survival for colon cancer patients was 67.2% compared with 60.1% for rectal cancer (p = 0.004). The most common sites of recurrence after pulmonary metastasectomy were liver in colon cancer and lung in rectal cancer. Multivariate Cox proportional hazards analysis indicated that rectal cancer (hazard ratio, 1.39; 95% confidence interval, 1.07 to 1.83; p = 0.015) and multiple metastases (>3; hazard ratio, 1.41; 95% confidence interval, 1.04 to 1.89; p = 0.027) were independent adverse risk factors affecting disease-free survival after pulmonary metastasectomy. Conclusions. Disease-free survival and site of recurrence after pulmonary metastasectomy for colorectal carcinoma are dependent on the site of the primary tumor. Lung metastases from rectal cancer have a worse disease-free survival compared with colon cancer. This may influence treatment and follow-up strategies. (C) 2014 by The Society of Thoracic Surgeons
引用
收藏
页码:1231 / 1237
页数:7
相关论文
共 50 条
  • [41] The prognostic importance of the number of metastases in pulmonary metastasectomy of colorectal cancer
    Jong Ho Cho
    Seok Kim
    Mi Namgung
    Yong Soo Choi
    Hong Kwan Kim
    Jae Ill Zo
    Young Mog Shim
    Jhingook Kim
    World Journal of Surgical Oncology, 13
  • [42] The prognostic importance of the number of metastases in pulmonary metastasectomy of colorectal cancer
    Cho, Jong Ho
    Kim, Seok
    Namgung, Mi
    Choi, Yong Soo
    Kim, Hong Kwan
    Zo, Jae Ill
    Shim, Young Mog
    Kim, Jhingook
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [43] Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis
    Fiorentino, Francesca
    Hunt, Ian
    Teoh, Kristine
    Treasure, Tom
    Utley, Martin
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2010, 103 (02) : 60 - 66
  • [44] Pulmonary Metastasectomy for Colorectal Cancer: Randomized Controlled Trial Response
    Gemmete, Joseph J.
    RADIOLOGY, 2021, 298 (01)
  • [45] A narrative review of minimally invasive pulmonary metastasectomy for colorectal cancer
    Sheth, Megha K.
    Harano, Takashi
    VIDEO-ASSISTED THORACIC SURGERY, 2024, 9
  • [46] Is the mediastinal lymphadenectomy during pulmonary metastasectomy of colorectal cancer necessary?
    Szoeke, Tamas
    Kortner, Ariane
    Neu, Rainer
    Grosser, Christian
    Sziklavari, Zsolt
    Wiebe, Karsten
    Hofmann, Hans-Stefan
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2010, 10 (05) : 694 - 698
  • [47] Prognosis in stage II colorectal cancer: The effect of the primary tumor location and biomarkers
    Liegeois, V.
    Colebunders, J.
    Mullebrouck, B.
    Vanhoutte, G.
    Van Damme, N.
    Peeters, M.
    Janssens, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S424 - S424
  • [48] Finding the evidence for pulmonary metastasectomy in colorectal cancer: the PulMicc trial
    Migliore, Marcello
    Milosevic, Misel
    Lees, Belinda
    Treasure, Tom
    Di Maria, Giuseppe
    FUTURE ONCOLOGY, 2015, 11 (02) : 15 - 18
  • [49] Pulmonary metastasectomy for colorectal cancer: weak evidence and no randomised trials
    Treasure, Tom
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 33 (02) : 300 - 302
  • [50] OUTCOMES OF EXTENDED SURGICAL CRITERIA FOR PULMONARY METASTASECTOMY OF COLORECTAL CANCER
    Ohde, Yasuhisa
    Saisho, Shinsuke
    Isaka, Mitsuhiro
    Maniwa, Tomohiro
    Nakagawa, Kazuo
    Okumura, Takehiro
    Kondo, Haruhiko
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S885 - S886